Literature DB >> 343869

Naftidrofuryl for intermittent claudication: a double-blind controlled trial.

C V Ruckley, M J Callam, C M Ferrington, R J Prescott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 343869      PMCID： PMC1603360          DOI： 10.1136/bmj.1.6113.622

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  1 in total

1.  Muscle blood-flow studies by the technetium (99mTc) clearance technique in normal subjects and in patients with intermittent claudication.

Authors:  C L Cutajar; N J Brown; A Marston
Journal:  Br J Surg       Date:  1971-07       Impact factor: 6.939
  1 in total
  4 in total

Review 1.  Pharmacological approaches to the treatment of intermittent claudication.

Authors:  E G Bevan; P C Waller; L E Ramsay
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

2.  Claudication.

Authors:  V C Ruckley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-12

Review 3.  Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.

Authors:  L B Barradell; R N Brogden
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

Review 4.  Naftidrofuryl for intermittent claudication.

Authors:  Tine L M de Backer; Robert Vander Stichele; Philippe Lehert; Luc Van Bortel
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.